BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

CR Pharma intends to make strategic equity investment for Everest's mRNA technology platform

Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...

April 07, 2022 | News

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...

April 05, 2022 | News

Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in China

On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"), completed the first sale of Ascletis' ritonavir tablets...

April 05, 2022 | News

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics. T...

April 04, 2022 | News

CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs

Hasten fast-tracks transformative medicines for patients in China Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has ...

April 01, 2022 | News

Biocytogen Expands Global Footprint

Local government representatives, clinical experts, and colleagues and collaborators from multi-national companies made speeches at the opening ceremony. D...

March 29, 2022 | News

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...

March 28, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia

The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...

March 23, 2022 | News

WuXi Biologics Achieved Record Growth and Profitability in 2021

WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group," stock code: 2269.HK), a global Contract Research, Development and Manufacturing Organization...

March 23, 2022 | News

Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules

These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...

March 22, 2022 | News

China CDE Approved First Universal CAR-T IND !

"The approval of CTA101 product IND is an important milestone for Bioheng in developing innovative immuno-cell therapies", said Xiaohong He, CEO of Bi...

March 18, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

March 18, 2022 | News

China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...

March 14, 2022 | News

Sinocompound announces commercial-scale production of QPhos ligand

Sinocompound Catalysts Co., Ltd, a global provider of advanced homogeneous catalysts and ligands, has announced production of the phosphine-based QPhos lig...

March 14, 2022 | News

Stay Connected